Related Experiment Video
Updated: Jul 1, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Dementia prevention: methodological explanations for inconsistent results
Nicola Coley1, Sandrine Andrieu, Virginie Gardette
1INSERM Unit 558, Toulouse, France. coley@cict.fr
Epidemiologic Reviews
|September 10, 2008
Summary
Preventing neurodegenerative dementias like Alzheimer disease is crucial. While lifestyle and some medications show promise in observational studies, randomized trials often conflict, highlighting the need for better research designs.
Area of Science:
- Neuroscience
- Public Health
- Epidemiology
Background:
- Neurodegenerative dementias, including Alzheimer disease, pose a significant public health challenge due to limited treatments and increasing prevalence.
- Epidemiological research has identified potential modifiable risk and preventive factors, such as lifestyle choices (social contact, exercise, diet) and pharmacologic strategies (hormone therapy, NSAIDs, Ginkgo biloba).
Purpose of the Study:
- To review epidemiological data on factors associated with dementia and cognitive decline.
- To discuss methodological limitations that may explain discrepancies between observational findings and intervention trial results.
Main Methods:
- Comprehensive literature review of epidemiological studies and randomized controlled trials.
- Analysis of conflicting evidence regarding dementia prevention strategies.
Main Results:
- Observational studies consistently identify various risk and protective factors for dementia.
- Few randomized controlled trials specifically validate these factors' protective effects on dementia incidence.
- Conflicting results between observational data and intervention trials are common.
Conclusions:
- Multifactorial dementia prevention may benefit from multidomain interventions.
- Designing robust clinical trials for multidomain dementia prevention remains a significant research challenge.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:12What is an Experiment?
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: